WO1987003586A1 - Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives - Google Patents
Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives Download PDFInfo
- Publication number
- WO1987003586A1 WO1987003586A1 PCT/HU1986/000067 HU8600067W WO8703586A1 WO 1987003586 A1 WO1987003586 A1 WO 1987003586A1 HU 8600067 W HU8600067 W HU 8600067W WO 8703586 A1 WO8703586 A1 WO 8703586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- general formula
- process according
- acid
- compounds
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/022—Boron compounds without C-boron linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/58—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
Definitions
- This invention re lates to a new proce ss f or the pre paration of 7-substituted-6-fluoro-1-methylamino-4-oxo-1, 4-dihydro-quinoline-3-carboxylic acid derivatives and pharmaceutically acce ptab le salts there of .
- the said compounds can be prepared by reacting 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylie acid with a cyclic amine in pyridine or methoxyethanol, at the boiling point, under a protecting nitrogen atmosphere for 15-22 hours (European patent specification No. 90, 424; Japanese patent specification No. 84 01,468; Journal of Medicinal Chemistry 25, 377 /1984/).
- R 1 and R 2 stand for halogen; an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally substituted be halogen; or an aromatic acyloxy group comprising 7-11 carbon atoms
- R 1 and R 2 stand for halogen; an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally substituted be halogen; or an aromatic acyloxy group comprising 7-11 carbon atoms
- the process of the present invention enables the preparation of the compounds of the general Formula I in a simple manner, with very high yields and in a short reaction time.
- the borate derivatives of the general Formula IV are converted into the desire quinoline-3-carboxylic acids of the general Formula I without isolation.
- the borate derivatives of the general Formulae II and IV are new compounds.
- reaction of the borate derivative of the general Formula II and the cyclic amine of the general For mula III may be carried out optionally in the presence of an inert organic solvent and an acid binding agent.
- inert organic solvent e.g. an acid amide (e.g. dimethyl formamide, dimethyl acetamide), a ketone (e.g. acetone, methyl ethyl ketone), an ether (e.g. dioxane, tetrahydrofuran, diethyl ether), an ester (e.g. ethyl acetate, methyl acetate, ethyl propionate), a sulfoxide (e.g. dimethyl sulfoxide), an alcohol (e.g. methanol, ethanol, 1-decanol, butanol, etc.) may be used.
- acid amide e.g. dimethyl formamide, dimethyl acetamide
- a ketone e.g. acetone, methyl ethyl ketone
- an ether e.g. dioxane, tetrahydrofuran, diethyl ether
- an ester
- acid binding agent e.g. organic or inorganic bases
- organic bases preferably trialkyl amines (e.g. triethyl amine, tributyl amine), cyclic amines (e.g. pyridine, 1,5-diazabicyclo/5.4.0/undec-5-ene, 1,5-diazabicyclo/4.3.0/non-5-ene, 1,4-diazabicyclo/2.2.2/octane) may be mentioned, while as inorganic base e.g. hydroxides or carbonates of alkali or alkaline earth metals may be applied. Thus it is preferred to use potaasium carbonate, potassium hydroge carbonate, sodium hydroxide, calcium hydroxide or an excess of the amine of the general Formula III as acid binding agent.
- inorganic base e.g. hydroxides or carbonates of alkali or alkaline earth metals may be applied.
- the reaction of the borone derivative of the general Formula II and the amine of the general Formula III may be carried out at a temperature of 0-200 °C durcing 0.5-10 hours, depending on the solvent used.
- the reaction time depends on the reaction temperature too. If the reaction temperature is raised, the reaction time can be shortened.
- the above reaction conditions are but preferable intervals, while other reaction conditions can be applied as well.
- the borate of the general Formula IV thus obtained is subjected to acidic or basic hydrolysis - after or without isolation - to yield the desired quinoline-3-carboxylic acid derivative of the general Formula I.
- the reaction product of the general Formula IV may be isolated e.g. by cooling the reaction mixture and separating the precipitated product e.g. by filtration or centrifuging.
- Alkaline hydrolysis can preferably be carried out with the aid of a hydroxide or carbonate of an alkali metal or an alkaline earth metal hydroxide, preferably in the form of an aqueous solution.
- a hydroxide or carbonate of an alkali metal or an alkaline earth metal hydroxide preferably in the form of an aqueous solution.
- One may particularly preferably proceed by hydrolysing. the compound of the general Formula IV by means of heating with an aqueous solution of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium hydrogen carbonate, potassium carbonate or calcium hydroxide.
- Hydrolysis may also be accomplished with the aid of an organic base (e.g. triethyl amine).
- Acidic hydrolysis may preferably be carried out by using an aqueous mineral acid solution.
- One may particularly advantageously proceed by heating with an aqueous hydrochloric acid, hydrogen bromide, suIfuric acid or phosphoric acid solution.
- Hydrolysis may also be accomplished with the aid of an organic acid (e.g. acetic acid, propionic acid, etc.).
- the hydrolysis of the compounds of the general Formula IV may also be carried out in the presence of a water-miscible organic solvent.
- a water-miscible organic solvent e.g. alcohols (e.g. methanol, ethanol), ketones (e.g. acetone), ethers (e.g. dioxane), acid amides (e.g. formamide, dimethyl formamide), sulfoxides (e.g. dimethyl sulfoxide) and pyridine may be used.
- the quinoline-3-carboxylie acid derivatives of the general Formula I thus obtained may be isolated e.g. by adjusting the pH value to a suitable value and separating the precipitated crystals e.g. by centrifuging, filtration, or by liophylisation of the aqueous solution.
- the quinoline-3-carboxylic acids of the general Formula I can be converted into the pharmaceutically acceptable salts thereof.
- One may preferably form acid addition salts, e.g. salts formed with hydrogen halidea, sulfonic acids, sulfuric acid or organic acids. Thua e.g. the chloridea, bromidea, 4-methyl-phenyl-sulfonates, methaneaulf onatea, maleatea, fumaratea, benzonatea, etc. can be formed.
- the compounda of the general Formula I form salts with alkali or alkaline earth metals or other metal ions too; thus e.g. the sodium, potassium, magnesium, silver, copper salts, etc. can be prepared.
- hydrates e.g. hemihydratea, trihydratea
- the hydrates (e.g. hemihydratea, trihydratea) of the compounda of the general Formula I or pharmaceutically acceptable acid addition salts thereof may also prepared, if desired, by methods known per se.
- the starting materials of the general Formula II can be prepared e.g. by reacting 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxy lie acid (European patent specification No. 90,424) with various borone derivatives, e.g. with a borone derivative of the general Formula V 1
- R 1 , R 2 are as stated above and R 4 has the aame meaning aa R 1 or R 2 ) orfluoro boric acid in an aqueous or organic medium.
- the reaction mixture is cooled to 80 C, whereupon 58 ml of a 6 weight/vol % aqueous sodium hydroxide solution are added within 5 minutes .
- the reaction mixture is heated to boiling and stirred for 2 houra under alight boiling.
- the aolution is cooled to room temperature and the pH ia adjusted to 7.2 by adding acetic acid.
- the crystalline mixture thus obtained ia allowed to crystallize in a refrigerator overnight .
- the precipitated crystals are fi ltered , washed twice with 10 ml of water each and with 5 ml of methanol.
- reaction mixture is filtered, the filtrate is evaporated in vacuo to two-third of its volume and the pH of the solution is adjusted to 6.5-7 by adding acetic acid.
- the reaction mixture is allowed to cryatallize in a refrigerator overnight.
- the precipitated crystala are filtered, waahed twice with 10 ml of water each and with 5 ml of methanol. Thua 5.3 g of 6-fluoro-1-ethylamino-7-piperazino-4-cxo-1,4-dihydro-quinoline-3-earboxylic acid are obtained. Yield: 82 %.
- Mp. 289-291 °C (decompoaition; from dimethyl formamide).
- a mixture of 1 g of 6-fluoro-1-methylamino-7-piperazino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid and 1.5 ml of water is treated with 0.6 g of p-toluene-sulfonic acid and the mixture is poured into 10 ml of methyl ethyl ketone.
- the reaction mixture is allowed to crystallize in a refrigerator overnight. Next morning the precipitated crystals are filtered and waahed with methyl ethyl ketone.
- the reaction mixture is cooled to 40o C and the pH is adjusted to 6.5 by adding 96 % by W/V acetic acid whereafter the suspension is diluted.
- the precipitated crystals are filtered and washed with water and abs. ethanol. Yellowish-beige 6-fluoro-1,4-dihydro-1-(methylamino)-7-piperazino-4-oxo-3-quinoline-carboxylic acid (0.42 g. 65 %) is obtained.
- a mixture of 1.42 g of boric acid and 10.7 g of propionic anhydride is stirred at 100 °C for 15 minutes whereupon the reaction mixture is heated to boiling point. After 30 minutes the temperature of the reaction mixture is lowered to 110o C and 4.2 g of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid are added. After some minutes the precipitation of crystals begins. The reaction mixture is stirred at 110 °C for 2 hours, cooled to 10 °C, whereupon 20 ml of water and 20 ml of ethanol are added to the crystalline suspension. The reaction mixture is allowed to crystallize in a refrigerator overnight.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Peptides Or Proteins (AREA)
- Quinoline Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Process for the preparation of compounds of general formula (I), and pharmaceutically acceptable salts thereof (wherein R stands for piperazinyl or 4-methyl-piperazinyl) which comprises reacting a compound of general formula (II), (wherein R1 and R2 stand for halogen; an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally substituted by halogen; or an aromatic acyloxy group comprising 7-11 carbon atoms) with a piperazine of general formula (III), (wherein R3 represents hydrogen or methyl) or a salt thereof, hydrolysing the compound of general Formula (IV), thus obtained (wherein R, R1 and R2 are as stated above) without or after hydrolysis and if desired converting the compound of general formula (I) thus obtained into a salt thereof or setting free the same from its salt. The compounds of general formula (I) are known antibacterial agents. The advantage of the process of the present invention is that it enables the preparation of the compounds of general formula (I) in a simple manner, with high yields and in a short reaction time.
Description
PROCESS FOR THE PREPARATION OF 1-METHYLAMINO-QUTNOLINE-CARBOXYLIC ACID DERIVATI VES
This invention re lates to a new proce ss f or the pre paration of 7-substituted-6-fluoro-1-methylamino-4-oxo-1, 4-dihydro-quinoline-3-carboxylic acid derivatives and pharmaceutically acce ptab le salts there of .
It is known that 6-fluoro -1-methylamino-4-oxo-1 , 4-dihydro-quinoline-3-carboxylic acid derivative s of the general Formula I
(wherein R stands for piperazinyl or 4-methyl-piperazinyl) exhibit outstanding antibacterial effect (Journal of Medicinal Chemistry 1984, 27, 1103; Antimicroba Agents and Chemotherapy 1984, 25 , 377; 1984, 26, 104; 275; 421; 781; 933; 1985, 27, 4 and 499; European Journal of Clinical Microbiology 1984, 3, 344; Clin. Therapy 1984, 7, 73).
The said compounds can be prepared by reacting 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylie acid with a cyclic amine in
pyridine or methoxyethanol, at the boiling point, under a protecting nitrogen atmosphere for 15-22 hours (European patent specification No. 90, 424; Japanese patent specification No. 84 01,468; Journal of Medicinal Chemistry 25, 377 /1984/).
According to the present invention there is provide a process for the preparation of compounds of the general Formula I and pharmaceutically acceptable salts thereof (wherein R stands for piperazinyl or 4-methyl-piperazinyl) which comprises reacting a compound of th general Formula II
(wherein R3 represents hydrogen or methyl) or a salt
thereof, hydrolysing the compound of the general Formula IV
thus obtained (wherein R, R1 and R2 are as stated above) without or after hydrolysis and if desired converting the compound of the general Formula I thus obtained into a salt thereof or setting free the same from its salt.
The process of the present invention enables the preparation of the compounds of the general Formula I in a simple manner, with very high yields and in a short reaction time.
According to a preferred form of realization of the process of the present invention the borate derivatives of the general Formula IV are converted into the desire quinoline-3-carboxylic acids of the general Formula I without isolation.
The borate derivatives of the general Formulae II and IV are new compounds.
The reaction of the borate derivative of the general Formula II and the cyclic amine of the general For
mula III may be carried out optionally in the presence of an inert organic solvent and an acid binding agent.
As inert organic solvent e.g. an acid amide (e.g. dimethyl formamide, dimethyl acetamide), a ketone (e.g. acetone, methyl ethyl ketone), an ether (e.g. dioxane, tetrahydrofuran, diethyl ether), an ester (e.g. ethyl acetate, methyl acetate, ethyl propionate), a sulfoxide (e.g. dimethyl sulfoxide), an alcohol (e.g. methanol, ethanol, 1-decanol, butanol, etc.) may be used.
As acid binding agent e.g. organic or inorganic bases can be used. From the group of organic bases preferably trialkyl amines ( e.g. triethyl amine, tributyl amine), cyclic amines (e.g. pyridine, 1,5-diazabicyclo/5.4.0/undec-5-ene, 1,5-diazabicyclo/4.3.0/non-5-ene, 1,4-diazabicyclo/2.2.2/octane) may be mentioned, while as inorganic base e.g. hydroxides or carbonates of alkali or alkaline earth metals may be applied. Thus it is preferred to use potaasium carbonate, potassium hydroge carbonate, sodium hydroxide, calcium hydroxide or an excess of the amine of the general Formula III as acid binding agent.
The reaction of the borone derivative of the general Formula II and the amine of the general Formula III may be carried out at a temperature of 0-200 °C durcing 0.5-10 hours, depending on the solvent used. The reaction time depends on the reaction temperature too. If the reaction temperature is raised, the reaction time can be shortened. The above reaction conditions are but preferable intervals, while other reaction conditions can be applied as well.
The borate of the general Formula IV thus obtained is subjected to acidic or basic hydrolysis - after or without isolation - to yield the desired quinoline-3-carboxylic acid derivative of the general Formula I. The reaction product of the general Formula IV may be isolated e.g. by cooling the reaction mixture and separating the precipitated product e.g. by filtration
or centrifuging.
Alkaline hydrolysis can preferably be carried out with the aid of a hydroxide or carbonate of an alkali metal or an alkaline earth metal hydroxide, preferably in the form of an aqueous solution. One may particularly preferably proceed by hydrolysing. the compound of the general Formula IV by means of heating with an aqueous solution of sodium hydroxide, potassium hydroxide, sodium carbonate, potassium hydrogen carbonate, potassium carbonate or calcium hydroxide. Hydrolysis may also be accomplished with the aid of an organic base (e.g. triethyl amine).
Acidic hydrolysis may preferably be carried out by using an aqueous mineral acid solution. One may particularly advantageously proceed by heating with an aqueous hydrochloric acid, hydrogen bromide, suIfuric acid or phosphoric acid solution. Hydrolysis may also be accomplished with the aid of an organic acid (e.g. acetic acid, propionic acid, etc.).
The hydrolysis of the compounds of the general Formula IV may also be carried out in the presence of a water-miscible organic solvent. For this purpose e.g. alcohols (e.g. methanol, ethanol), ketones (e.g. acetone), ethers (e.g. dioxane), acid amides (e.g. formamide, dimethyl formamide), sulfoxides (e.g. dimethyl sulfoxide) and pyridine may be used.
The quinoline-3-carboxylie acid derivatives of the general Formula I thus obtained may be isolated e.g. by adjusting the pH value to a suitable value and separating the precipitated crystals e.g. by centrifuging, filtration, or by liophylisation of the aqueous solution.
The quinoline-3-carboxylic acids of the general Formula I can be converted into the pharmaceutically acceptable salts thereof. One may preferably form acid
addition salts, e.g. salts formed with hydrogen halidea, sulfonic acids, sulfuric acid or organic acids. Thua e.g. the chloridea, bromidea, 4-methyl-phenyl-sulfonates, methaneaulf onatea, maleatea, fumaratea, benzonatea, etc. can be formed. The compounda of the general Formula I form salts with alkali or alkaline earth metals or other metal ions too; thus e.g. the sodium, potassium, magnesium, silver, copper salts, etc. can be prepared.
The hydrates (e.g. hemihydratea, trihydratea) of the compounda of the general Formula I or pharmaceutically acceptable acid addition salts thereof may also prepared, if desired, by methods known per se.
The starting materials of the general Formula II can be prepared e.g. by reacting 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxy lie acid (European patent specification No. 90,424) with various borone derivatives, e.g. with a borone derivative of the general Formula V 1
(wherein R1, R2 are as stated above and R4 has the aame meaning aa R1 or R2) orfluoro boric acid in an aqueous or organic medium.
Further details αf the preaent invention are to be found in the following Examplea without limiting the acope of protection to the aaid Examples.
Example 1
A mixture of 6.87 g of 4-methyl-piperazine and 7.26 g of an anhydride of 6-fluoro-7-ehloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylie acid and dif luoro boric acid formed with 36 ml of dimethyl
sulf oxide is stirred at 110 °C for 3 hours. As the reaction proceeds yellow crystals pre cipitate gradually from the reaction mixture . The anhydride of 6-fluoro-1-methylamino-7- (4-methyl-piperazino )-4-oxo-1,4-dihydr o-quinoline-3-carboxylic acid and difluoro boric acid thus formed is hydrolysed without isolation from the reaction mixture as follows :
The reaction mixture is cooled to 80 C, whereupon 58 ml of a 6 weight/vol % aqueous sodium hydroxide solution are added within 5 minutes . The reaction mixture is heated to boiling and stirred for 2 houra under alight boiling. The aolution is cooled to room temperature and the pH ia adjusted to 7.2 by adding acetic acid. The crystalline mixture thus obtained ia allowed to crystallize in a refrigerator overnight . Next morning the precipitated crystals are fi ltered , washed twice with 10 ml of water each and with 5 ml of methanol. Thus 5.8 g of 6-fluoro-1-methylamino-7- (4-methyl-piperazino )-4-oxo-1,4dihydro-quinoline-3-carboxylic acid are obtained, yield 76. 1 %. Mp. : 300-301 (decomposition; from dimethyl formamide ) .
Analysis for the Formula C1 6H19FN4 O3 calculated C = 57.47 %, H = 5.72 %, N = 16.75 %; found C = 57. 71 %, H = 5.70 %, N = 16.68 %.
Example 2
A mixture of 5. 18 g of piperazine and 6.37 g of an anhydride of 6-fluoro-7-chloro-1-methylamino-4-oxo-1, 4-dihydro-quinoline-3-carboxylic acid and difluoro boric acid formed with 32 ml of dimethyl aulfoxide is stirred at 110 °C for 3 houra. To the reaction mixture 51 ml of a 6 weight/vol % aqueoua aodium hydroxide aolution are added and the aqueoua reaction mixture ia atirred under slight boiling for 2 hours. The reaction mixture is filtered, the filtrate is evaporated in vacuo to two-third of its volume and the pH of the solution is adjusted to
6.5-7 by adding acetic acid. The reaction mixture is allowed to cryatallize in a refrigerator overnight. Next morning the precipitated crystala are filtered, waahed twice with 10 ml of water each and with 5 ml of methanol. Thua 5.3 g of 6-fluoro-1-ethylamino-7-piperazino-4-cxo-1,4-dihydro-quinoline-3-earboxylic acid are obtained. Yield: 82 %. Mp.: 289-291 °C (decompoaition; from dimethyl formamide).
Analyaia for the Formula C15H17FN4O3 calculated C = 56.24 %, H = 5.34 %, N = 12;49 %; fonnd C = 56.15 %, H = 5.37 %, N = 12.61 %.
A mixture of 1 g of 6-fluoro-1-methylamino-7-piperazino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid and 1.5 ml of water is treated with 0.6 g of p-toluene-sulfonic acid and the mixture is poured into 10 ml of methyl ethyl ketone. The reaction mixture is allowed to crystallize in a refrigerator overnight. Next morning the precipitated crystals are filtered and waahed with methyl ethyl ketone. Thus 1.3 of the p-toluene-aulfonate aalt of 6-fluoro-1-methylamino-7-piperazine-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid are obtained, yield: 84.5 %.
Analyaia for the Formula C15H17FN4O3 . C7H8O3S calculated C = 53.65 %, H = 5.11 %, N = 11.37%; found C = 53.89 %, H = 4.96 %, N = 11.25%.
Example 3
5 g of ethyl-6-fluoro-1-N-formyl-N-methylamino-7-chloro-4-oxo-1,4-dihydro-quinoline-3-carboxylate are atirred in 25 ml of a 50 weight/vol % aqueoua aolution of hydrogen fluoro borate at 90-95 °C for 4 houra. After one hour and a half the precipitation of cryatals gradually begina. The reaction mixture ia cooled to room temperature and allowed to cryatallize in a refrigerator overnight. Next morning the precipitated crystals are filtered and waahed with aome water. Thus
4.55 g of an anhydride of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid and difluoro boric acid are obtained. Yield: 93.4 %. Mp.: 277 °C (decomposition).
Analysis for the Formula C11H7BF3ClN2O3 calculated C = 41.48 %, H = 2.21 %, N = 8.79%; found C = 41.59 %, H = 2.34 %, N = 8.58%.
Exampl e 4
0.797 g. of [ 6-fluoro-7-chloro-1,4-dihydro-1-(methyl-amino)-4-oxo-3-quinoline-carboxylate-03 ,04]bis(acetate-0)-boron and 0.6 g. of 1-methyl-piperazine are reacted in the presence of 5 ml. of dimethylsulfoxide at 110 °C for 2 hours. Then an aqueous solution of 6 % by W/V sodium hydroxide (5.1 ml.) is added and stirred for another 1 hour at 110º C. The mixture is then cooled to 40 °C and the pH value is adjusted to 6.5 with 96 % by W/V acetic acid. The mixture is then cooled to room temperature whereupon crystals are precipitated. The mixture is allowed to stand in a refrigerator overnight, then diluted with 15 ml. of water and the precipitated crystals are filtered, and washed with water and cold methanol. 0.56 g. (84 % ) of 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4-methyl- -piperazino)-4-oxo-3-quinoline-carboxylic acid is obtained. Decomposition after recrystallization from dimethylformamide at 293 °C. Analysis for the formula C1 6H19FN4O3 calculated: C = 57.48 % H = 5.73 % N = 16.76 % found: C = 58.0 % H = 5.9 % N = 16.9 %
Preparation of the starting material
0.568 g. of boric acid and 3.28 g. of acetic acid anhydride are reacted in the presence of 1 mg. of zinc chloride while the temperature of the reaction mixture raises to 46 °C. The white suspension is slowly heated to 100 °C and 2.0 g. of ethyl[ 7-chloro6-fluoro-1,4-dihydro-1-(formylmethyl-amino)-4-oxo-3-quinoline-carboxylate] are added which had been previously dissolved in 10 ml. of 96 % by W/V acetic acid. The reaction mixture is further heated for 2 hours at 110º C. The solution is cooled to room temperature and diluted with 40 ml of cold water. The precipitated crystals are filtered, washed with water and cold abs. ethanol, dried. 1.75 g. off-white, crystalline [ 6-fluoro
-7-chloro-1,4-dihydro-1-(methyl-amino)-4-oxo-3-quinolinecarboxylate-03 ,04 ]-bis(acetate-0)-boron are obtained. Decomposition: 272º C.
Upon standing further 0.45 g. product crystallizes from the mother liquor. Analysis for the formula C15 H13BClFN2O7 calculated: C = 45.55 % H = 3.31 % N = 3.54 % found: C = 45.2 % H = 3.2 % N = 3.6 %.
Example 5
0.797 g. of [ 6-fluoro-7-chloro-1,4-dihydro-1- -(methylamino)-4-oxo-3-quinolinecarboxylate-03,04 ]bis(acetate-0)-boron and 0.52 g. of piperazine are reacted in the presence of 5 ml. of dimethylsulfoxide at 110 °C for 2 hours. An aqueous solution of 6 % by W/V sodium hydroxide (5 ml.) is then added to the reaction mixture which is then mildly boiled for 1 hour. The first crystals precipitate after 10 minutes. The reaction mixture is cooled to 40º C and the pH is adjusted to 6.5 by adding 96 % by W/V acetic acid whereafter the suspension is diluted. The precipitated crystals are filtered and washed with water and abs. ethanol. Yellowish-beige 6-fluoro-1,4-dihydro-1-(methylamino)-7-piperazino-4-oxo-3-quinoline-carboxylic acid (0.42 g. 65 %) is obtained.
Analysis for the formula: C15H1 7FN4O3 calculated: C = 56.24 % H = 5.35 % N = 17.49 % found: C = 55.9 % H = 5.5 % N = 17.8 %.
Example 6
0.426 g. [ 6-fluoro-7-chloro-1,4-dihydro-1-(methylamino)-4-oxo-3-quinoline-carboxylate-03,04 ]bis(propanoate-0)-boron and 0.3 g. of 1-methyl-piperazine are reacted in the presence of 2.5 ml. of dimethylsulfoxide for 2 hours at 110º C. Then an aqueous solution of 6 % by W/V of sodium hydroxide (2.5 ml.) is added
and the mixture is further heated for 1 hour at the above temperature. The reaction mixture is then cooled to 40 °C and the pH is adjusted to 6.5 by adding 96 % by W/V acetic acid. Crystals immediately precipitate.
The reaction mixture is allowed to stand overnight in the refrigerator and the precipitated crystals are filtered, washed with some water and methanol. Thus 0.22 g.
( 66 %) of 6-fluoro-1,4-dihydro-1-(methylamino)-7-(4¬
-methyl-piperazine)-4-oxo-3-quinoline-carboxylie acid is obtained, decomposing at 294 °C after recrystallization from dimethylformamide. No depression of the melting point is observed when admixing the product at any ratio with the product of the previous Example.
Preparation of the starting material
1.
5 g. of ethyl-6-fluoro-1-(N-formyl-N-methyl-amino)-7-chloro-4-oxo-1,4-dihydro-quinoline-3-carboxylate are stirred in 25 ml of an 50 weight/vol % aqueous colution of hydrogen fluoroboric acid at 90-95 °C for 4 hours. After one hour and a half the precipitation of crystals begins. The reaction mixture is cooled to room temperature, then placed into a refrigerator and allowed to crystallize overnight. The precipitated crystals are filtered next morning and washed with some water. Thus 4.55 g of an anhydride of 6-fluoro-7-chloro-1-(methylamino)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid and difluoro boric acid are obtained, yield: 93.4 %. Mp.: 277 °C (decomposition). Analysis for the formula C11H7BF3ClN2O3 calculated: C = 41.48 %, H = 2.21 %, N = 8.79 % found: C = 41.59 %, H = 2.34 % N = 8.58 %.
2.
5 g. of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid are stirred in 25 ml of a 50 weight/vol % aqueous solution of
hydrogen fluoro boric acid at 80-90 °C for 2 hours. After 45 minutes the precipitation of crystals begins. The reaction mixture is first cooled to room temperature and then allowed to crystallize for 2 hours at 0º C. The precipitated crystals are filtered, and washed with some water. Thus 4.95 g of an anhydride of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid and difluoro boric acid are obtained, yield 84.5 % . Mp.: 277º C (decomposition). A mixture of the product thus obtained with any amount of the compound prepared according to Example 1 shows no melting point depression.
A mixture of 1.42 g of boric acid and 10.7 g of propionic anhydride is stirred at 100 °C for 15 minutes whereupon the reaction mixture is heated to boiling point. After 30 minutes the temperature of the reaction mixture is lowered to 110º C and 4.2 g of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid are added. After some minutes the precipitation of crystals begins. The reaction mixture is stirred at 110 °C for 2 hours, cooled to 10 °C, whereupon 20 ml of water and 20 ml of ethanol are added to the crystalline suspension. The reaction mixture is allowed to crystallize in a refrigerator overnight. The precipitated crystals are filtered, washed with water and dried. Thus 6.12 g of (6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydro-quinoline-3-carboxylicacid-borone-dipropionyloxy)-anhydride are obtained. Yield: 93.5 %, mp.: 215º C (decomposition). Analysis for the formula C17H17BFClN2O7 calculated: C = 47.86 %, H = 4.01 %, N = 6.56 %, found: C = 48.07 %, H = 3.87 %, N = 6.48 % .
Claims
1. Process for the preparation of compounda of the general Formula I
and pharmaceutically acceptable aalta thereof (wherein R atanda for piperazinyl or 4-methyl_piperazinyl) which comprises reacting a compound of the general Formula II
(wherein R3 represents hydrogen or methyl) or a salt thereof, hydrolysing the compound of the general Formula IV
2. Process according to Claim 1 which comprises carrying out the reaction of the compounds of the general Formula II and III (wherein R1, R2 and R3 are as stated in Claim 1) in the presence of an organic solvent, preferably an acid amide, sulfoxide, ketone, alcohol, ether or ester.
3. Process according to Claim 2 which comprises using dimethyl suIfoxide as organic solvent.
4. Process according to Claim 1 which comprises reacting the compounds of the general Formulae II and III in the presence of an acid binding agent.
5. Process according to Claim 4 which comprises using an amine or an excess of the compound of the general Formula III as acid binding agent.
6. Process according to Claim 1 which comprises carrying out hydrolysis in acidic medium.
7. Process according to Claim 6 which comprises using an organic or inorganic acid, preferably hydrochloric acid, sulfuric acid, or acetic acid.
8. Process according to Claim 1 which comprises carrying out hydrolysis in alkaline medium.
9. Process according to Claim 8 which comprises using an alkali metal hydroxide, alkaline earth metal hydroxide or an organic baae, preferably an aqueous solution of triethy1 amine.
10. Compounds of the general Formula IV (wherein
R stands for piperazinyl or 4-methyl-piperazinyl and
R1 and R2 represent halogen; an aliphatic acyloxy group comprising 2-6 carbon atoms and optionally substituted by halogen; or an aromatic acyloxy group comprising 7-11 carbon atoms).
11. Compounds of the general Formula I whenever prepared by the process according to any of Claim 1-9.
12. A proceas as substiantially described herein with particular reference to the Examples.
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019870700632A KR940008304B1 (en) | 1985-12-09 | 1986-12-09 | Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives |
| EP87900245A EP0248876B1 (en) | 1985-12-09 | 1986-12-09 | Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives |
| FI873097A FI86420C (en) | 1985-12-09 | 1987-07-13 | FOERFARANDE FOER FRAMSTAELLNING AV 1-METHYLAMINOQUINOLINE-CARBOXYL SYRADERIVAT. |
| NO873097A NO170153C (en) | 1985-12-09 | 1987-07-23 | PREPARATION OF 1-METHYLAMINOKINOLINCARBOXYL ACID DERIVATIVES |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU854691A HU196782B (en) | 1985-12-09 | 1985-12-09 | Process for production of quinoline carbonic acid |
| HU4691/85 | 1985-12-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1987003586A1 true WO1987003586A1 (en) | 1987-06-18 |
Family
ID=10968683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/HU1986/000067 Ceased WO1987003586A1 (en) | 1985-12-09 | 1986-12-09 | Process for the preparation of 1-methylamino-quinoline-carboxylic acid derivatives |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4871849A (en) |
| EP (1) | EP0248876B1 (en) |
| KR (1) | KR940008304B1 (en) |
| AT (1) | ATE119884T1 (en) |
| CA (1) | CA1294621C (en) |
| CS (1) | CS261250B2 (en) |
| DD (1) | DD252602A5 (en) |
| FI (1) | FI86420C (en) |
| HU (1) | HU196782B (en) |
| NO (1) | NO170153C (en) |
| SU (1) | SU1579459A3 (en) |
| WO (1) | WO1987003586A1 (en) |
| YU (1) | YU45392B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR880100232A (en) * | 1987-04-08 | 1989-01-31 | Chinoin Gyogyszer Es Vegyeszet | Quinoline carboxylic acid boric acid anhydrides and process for the preparation therefor |
| WO1990006922A1 (en) * | 1988-12-22 | 1990-06-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Process for the preparation of quinoline carboxylic acid derivatives |
| US5380845A (en) * | 1987-06-24 | 1995-01-10 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. | Process for the preparation of quinoline carboxylic acid derivatives |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU198709B (en) * | 1987-04-08 | 1989-11-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing quinoline-carboxylic acid derivatives |
| AU2003203088A1 (en) * | 2002-02-07 | 2003-09-02 | Browne And Co. Ltd. | Non-symmetrical photo tooling and dual surface etching |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6011913B2 (en) * | 1977-12-27 | 1985-03-28 | 広栄化学工業株式会社 | 1,8-naphthyridine derivative and its manufacturing method |
| DE3363711D1 (en) * | 1982-03-31 | 1986-07-03 | Sterling Drug Inc | New quinolone compounds and preparation thereof |
| JPS5980683A (en) * | 1982-10-30 | 1984-05-10 | Koei Chem Co Ltd | 6-fluoro-1,8-naphthyridine derivative and its preparation |
| AU553415B2 (en) * | 1983-09-19 | 1986-07-17 | Abbott Japan Co., Ltd. | 6-fluoro-1-4-dihydro-4-oxo-7-substituted piperazinyl- quinoline-3-carboxylic acids |
-
1985
- 1985-12-09 HU HU854691A patent/HU196782B/en not_active IP Right Cessation
-
1986
- 1986-12-08 CA CA000524727A patent/CA1294621C/en not_active Expired - Lifetime
- 1986-12-09 EP EP87900245A patent/EP0248876B1/en not_active Expired - Lifetime
- 1986-12-09 YU YU2105/86A patent/YU45392B/en unknown
- 1986-12-09 KR KR1019870700632A patent/KR940008304B1/en not_active Expired - Fee Related
- 1986-12-09 CS CS869090A patent/CS261250B2/en unknown
- 1986-12-09 DD DD86297302A patent/DD252602A5/en not_active IP Right Cessation
- 1986-12-09 US US07/105,299 patent/US4871849A/en not_active Expired - Fee Related
- 1986-12-09 WO PCT/HU1986/000067 patent/WO1987003586A1/en not_active Ceased
- 1986-12-09 AT AT87900245T patent/ATE119884T1/en active
-
1987
- 1987-07-13 FI FI873097A patent/FI86420C/en not_active IP Right Cessation
- 1987-07-23 NO NO873097A patent/NO170153C/en unknown
- 1987-08-07 SU SU874203110A patent/SU1579459A3/en active
Non-Patent Citations (2)
| Title |
|---|
| CHEMICAL ABSTRACTS, Vol. 102, No. 7, issued 1985, February 18 (Columbus, Ohio, USA), Daiichi Seiyaku "1-Ethyl-6-Fluoro-4-Oxo-7- -(1-Piperazinyl)-1, 4-Dihydroquinoline-3- -Carboxylic Acids", see page 605, column 1, Abstract-No. 62 272y & JP, A, 59-122 470 (Daiichi Seiyaku) 14 July 1984 * |
| CHEMICAL ABSTRACTS, Vol. 103, No. 15, issued 1985, October 14 (Columbus, Ohio, USA), Daiichi Seiyaku "Oxazines", see page 730, column 1, Abstract-No. 123 491p & JP, A, 60-78 986 (Daiichi Seiyaku) 04 May 1985 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR880100232A (en) * | 1987-04-08 | 1989-01-31 | Chinoin Gyogyszer Es Vegyeszet | Quinoline carboxylic acid boric acid anhydrides and process for the preparation therefor |
| US4940794A (en) * | 1987-04-08 | 1990-07-10 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara/Rt. | Quinoline carboxylic acid boric acid anhydrides |
| US5380845A (en) * | 1987-06-24 | 1995-01-10 | Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. | Process for the preparation of quinoline carboxylic acid derivatives |
| WO1990006922A1 (en) * | 1988-12-22 | 1990-06-28 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Process for the preparation of quinoline carboxylic acid derivatives |
| GB2245562A (en) * | 1988-12-22 | 1992-01-08 | Chinoin Gyogyszer Es Vegyeszet | Process for the preparation of quinoline carboxylic acid derivatives |
| GB2245562B (en) * | 1988-12-22 | 1992-12-23 | Chinoin Gyogyszer Es Vegyeszet | Process for the preparation of quinoline carboxylic acid derivatives |
| AT397385B (en) * | 1988-12-22 | 1994-03-25 | Chinoin Gyogyszer Es Vegyeszet | METHOD FOR PRODUCING CHINOLINE CARBONIC ACID DERIVATIVES |
Also Published As
| Publication number | Publication date |
|---|---|
| FI873097A7 (en) | 1987-07-13 |
| NO170153C (en) | 1992-09-16 |
| NO873097L (en) | 1987-07-23 |
| US4871849A (en) | 1989-10-03 |
| KR940008304B1 (en) | 1994-09-12 |
| FI86420C (en) | 1992-08-25 |
| SU1579459A3 (en) | 1990-07-15 |
| KR880700792A (en) | 1988-04-12 |
| NO170153B (en) | 1992-06-09 |
| HUT43840A (en) | 1987-12-28 |
| YU45392B (en) | 1992-05-28 |
| DD252602A5 (en) | 1987-12-23 |
| YU210586A (en) | 1987-12-31 |
| EP0248876A1 (en) | 1987-12-16 |
| FI873097A0 (en) | 1987-07-13 |
| FI86420B (en) | 1992-05-15 |
| NO873097D0 (en) | 1987-07-23 |
| HU196782B (en) | 1989-01-30 |
| CS261250B2 (en) | 1989-01-12 |
| ATE119884T1 (en) | 1995-04-15 |
| CA1294621C (en) | 1992-01-21 |
| CS909086A2 (en) | 1988-05-16 |
| EP0248876B1 (en) | 1995-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4981966A (en) | Process for the preparation of quinoline carboxylic acids | |
| US5091530A (en) | Baron chelates of quinoline carboxylic acids | |
| KR970005911B1 (en) | Process for preparing quinoline carboxylic acid derivatives | |
| US4871849A (en) | 1-Methylamino-quinoline-carboxylic acid derivatives | |
| EP0250535B1 (en) | Norfloxacin intermediate | |
| KR970005910B1 (en) | Method for preparing quinoline carboxylic acid | |
| US5294712A (en) | Process for the preparation of quinoline carboxylic acids | |
| JP2825641B2 (en) | Method for producing quinoline carboxylic acid derivative | |
| RU2049783C1 (en) | Method of synthesis of quinoline carboxylic acid derivatives or their pharmaceutically acceptable salts | |
| US5380845A (en) | Process for the preparation of quinoline carboxylic acid derivatives | |
| US5284950A (en) | Process for the preparation of quinoline carboxyolic acids | |
| WO1987003594A1 (en) | Amifloxacine intermediate | |
| HK1003996B (en) | Process for the preparation of quinoline carboxylic acids | |
| HU195801B (en) | Process for producing 1-ethyl-6-fluoro-7-piperazino-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): FI KR NO SU US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1987900245 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 873097 Country of ref document: FI |
|
| WWP | Wipo information: published in national office |
Ref document number: 1987900245 Country of ref document: EP |
|
| WWG | Wipo information: grant in national office |
Ref document number: 873097 Country of ref document: FI |
|
| WWG | Wipo information: grant in national office |
Ref document number: 1987900245 Country of ref document: EP |